for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Becton Dickinson and Co

BDX.N

Latest Trade

238.65USD

Change

3.81(+1.62%)

Volume

481,958

Today's Range

235.62

 - 

238.73

52 Week Range

197.75

 - 

286.67

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
234.84
Open
236.12
Volume
481,958
3M AVG Volume
30.48
Today's High
238.73
Today's Low
235.62
52 Week High
286.67
52 Week Low
197.75
Shares Out (MIL)
290.03
Market Cap (MIL)
66,405.58
Forward P/E
18.27
Dividend (Yield %)
1.45

Next Event

Becton Dickinson and Co at Evercore ISI HealthCONx Conference

Latest Developments

More

Becton Dickinson and Co Board Increases Dividend

Becton Dickinson Says Aware Of The Tweet By Elon Musk And Are Reaching Out To Learn More, Consistent With Our Quality Management Process - Tweet

Bd Acquires The Medical Business Assets Of Cubex LLC, Broadening Automated Dispensing Portfolio Across Care Continuum

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Industry

Medical Equipment & Supplies

Contact Info

1 Becton Dr

FRANKLIN LAKES, NJ

07417-1815

United States

+1.201.8476800

http://www.bd.com/

Executive Leadership

Vincent A. Forlenza

Executive Chairman of the Board

Thomas E. Polen

President, Chief Executive Officer, Chief Operating Officer, Director

Christopher R. Reidy

Chief Financial Officer, Executive Vice President, Chief Administrative Officer

Betty D. Larson

Executive Vice President- Human Resources, Chief Human Resources

John DeFord

Executive Vice President, Chief Technology Officer

Key Stats

2.06 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

16.0K

2019

17.3K

2020

17.1K

2021(E)

19.1K
EPS (USD)

2018

11.010

2019

11.680

2020

10.200

2021(E)

12.531
Price To Earnings (TTM)
83.91
Price To Sales (TTM)
3.88
Price To Book (MRQ)
2.79
Price To Cash Flow (TTM)
22.74
Total Debt To Equity (MRQ)
75.45
LT Debt To Equity (MRQ)
72.48
Return on Investment (TTM)
1.85
Return on Equity (TTM)
1.65

Latest News

Latest News

Musk questions coronavirus tests, saying they gave opposite results on same day

Tesla Inc <TSLA.O> Chief Executive Officer Elon Musk questioned the accuracy of COVID-19 tests on Thursday after claiming that results showed he tested positive twice and then negative twice all on the same day.

BRIEF-Becton Dickinson Says Aware Of The Tweet By Elon Musk And Are Reaching Out To Learn More, Consistent With Our Quality Management Process - Tweet

* BECTON DICKINSON SAYS AWARE OF THE TWEET BY ELON MUSK AND ARE REACHING OUT TO LEARN MORE, CONSISTENT WITH OUR QUALITY MANAGEMENT PROCESS - TWEET

UPDATE 3-Becton Dickinson sees COVID-19 test sales of up to $1.5 bln after profit beat

Medical device maker Becton Dickinson and Co said on Thursday it expects as much as $1.5 billion in sales from its COVID-19 diagnostic test next year, after reporting a quarterly profit that beat Wall Street estimates.

Becton Dickinson posts 16% fall in quarterly profit

Becton Dickinson and Co on Thursday posted a 16% fall in fourth-quarter profit, as the medical technology company was hurt by patients deferring discretionary procedures due to the COVID-19 pandemic.

UPDATE 1-Nevada's ban on Quidel and Becton Dickinson COVID-19 tests violates law -HHS official

Nevada's recent ban on the use of Quidel Corp's Sofia and Becton Dickinson and Co's Veritor point-of-care antigen tests for COVID-19 in long-term care facilities violates federal law, a U.S. government official said on Friday.

Nevada's prohibition of Quidel, Becton Dickinson's COVID-19 tests violates law: HHS official

U.S. state of Nevada's recent ban on the use of Quidel Corp's Sofia and Becton Dickinson and Co's (BD) Veritor point of care antigen tests in long-term care facilities violates federal law, a U.S. government official said on Friday.

Becton Dickinson says COVID-19 test kit meets requirements for Europe launch

U.S. medical device maker Becton Dickinson and Co said on Wednesday its COVID-19 antigen test kit met the requirements for a launch in Europe.

Becton Dickinson reaches $60 million settlement over pelvic mesh devices

Becton Dickinson and Co agreed to pay $60 million to resolve allegations by the attorneys general of 48 U.S. states and Washington D.C. that its CR Bard unit concealed the risks of its now-discontinued transvaginal pelvic mesh devices.

Becton Dickinson reaches $60 million settlement over pelvic mesh products

Becton Dickinson and Co said on Thursday it has reached a $60 million settlement with the attorneys general of 48 U.S. states and Washington, D.C. to settle litigation related to discontinued pelvic mesh products.

Becton Dickinson reaches $60 mln settlement over pelvic mesh products

Becton Dickinson and Co said on Thursday it has reached a $60 million settlement with the attorneys general of 48 U.S. states and Washington, D.C. to settle litigation related to discontinued pelvic mesh products.

NY sues Becton Dickinson unit over surgical mesh devices, consent judgment expected

New York's attorney general on Thursday filed a lawsuit accusing Becton Dickinson and Co's CR Bard unit of concealing the risks of surgical mesh devices.

Becton Dickinson probes false-positive COVID-19 test results in U.S. nursing homes

Becton Dickinson said on Tuesday it is investigating reports from U.S. nursing homes that its rapid coronavirus testing equipment is producing false-positive results.

Becton on track to make one billion syringes to help COVID-19 vaccination

Becton Dickinson and Co <BDX.N> said on Thursday it was on track to make 1 billion syringes in the next 12-18 months to meet demand for COVID-19 vaccination when approved, as the medical device maker reported quarterly revenue below estimates, sending its shares down nearly...

Becton Dickinson on track to produce one billion syringes in 12-18 months

Medical device maker Becton Dickinson and Co said on Thursday it would be able to produce 1 billion syringes in the next 12-18 months.

Becton Dickinson profit slumps nearly 37% on delayed surgeries

Medical technology company Becton Dickinson and Co on Thursday reported a 36.6% fall in quarterly profit, hurt by lower demand for its devices as people delayed non-urgent surgeries during the COVID-19 pandemic.

U.S. government agrees to buy Becton's COVID-19 testing devices

The U.S. government will buy Becton, Dickinson and Co's COVID-19 testing devices and kits, the company said on Wednesday, as it ramps up its testing for the virus that has been spreading at an alarming rate.

U.S. govt to invest $42 million in Becton Dickinson to ramp up vaccination efforts

Becton Dickinson and Co <BDX.N> said on Wednesday the U.S. government will invest $42 million to expand the medical technology company's manufacturing capacity for syringes and needles to support vaccination efforts against COVID-19.

U.S. govt to invest $42 mln in Becton Dickinson's injection device production

Becton Dickinson and Co said on Wednesday the U.S. government will invest $42 million to expand the medical technology company's manufacturing lines for injection devices to support vaccination efforts against COVID-19.

BRIEF-BD Launches First And Only Fully Sterile Povidone-Iodine And Isopropyl Alcohol Skin Preparation

* BD LAUNCHES FIRST AND ONLY FULLY STERILE POVIDONE-IODINE AND ISOPROPYL ALCOHOL SKIN PREPARATION

U.S. FDA alerts on false positive result from Becton Dickinson COVID-19 test

The U.S. Food and Drug Administration alerted clinical laboratories and healthcare providers on Monday about false positive results from one of Becton Dickinson and Co's COVID-19 molecular diagnostic tests.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up